<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04791566</url>
  </required_header>
  <id_info>
    <org_study_id>H-20038432</org_study_id>
    <nct_id>NCT04791566</nct_id>
  </id_info>
  <brief_title>Preoperative High-dose Dexamethasone and Emergency Laparotomy</brief_title>
  <official_title>The Effects of Preoperative High-dose Dexamethasone on Inflammatory Response and Recovery After Emergency Laparotomy, a Randomized, Double-blind, Placebo-controlled Clinical Trial - AHA STEROID TRIAL</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mirjana Cihoric</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Copenhagen University Hospital, Hvidovre</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this trial is to evaluate the effect of high-dose glucocorticoid on inflammatory&#xD;
      response and recovery after emergency laparotomy in participants with intestinal obstruction&#xD;
      and perforated viscus.&#xD;
&#xD;
      Primary outcome is the reduction of C-reactive protein on postoperative day 1. Secondary&#xD;
      outcomes are organ specific complications in the post anaesthesia phase, endothel and&#xD;
      inflammatory markers, fluid status, preload dependency, pain, lung function, nausea and&#xD;
      mobilization during the first 5 days after surgery, .&#xD;
&#xD;
      The investigators hypothesize, that a preoperative single high dose of glucocorticoid reduces&#xD;
      systemic inflammatory response after emergency laparotomy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Surgical trauma and accompanying inflammation results in increased capillary permeability&#xD;
      leading to tissue edema. Since the vascular endothelium contributes to homeostasis,&#xD;
      endothelial damage may increase the risk of cardiovascular and hemodynamic complications.&#xD;
&#xD;
      Pre-operative high-dose glucocorticoids provide reduction in the inflammatory response after&#xD;
      surgery, effective pain relief in several major surgical procedures, as well as reducing&#xD;
      fatigue, impairing endothelial dysfunction, potentially amend fluid extravasation, edema and&#xD;
      dyscoagulation and vasodilation.&#xD;
&#xD;
      However, glucocorticoids have not been assessed in patients with peritonitis or intestinal&#xD;
      obstruction, specifically, the impact on pain, fluid dynamics, respiratory as well as&#xD;
      endothelial function and mobilization in both obstruction and perforation.&#xD;
&#xD;
      In this study, patients will be randomized to either high dose dexamethason (1 mg /kg) or&#xD;
      placebo (0,9% NaCl), administered as a single dose preoperatively. The investigatoris&#xD;
      hypothesize that a preoperative single high dose of glucocorticoid reduces systemic&#xD;
      inflammatory response after emergency laparotomy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2021</start_date>
  <completion_date type="Anticipated">June 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>plasma C-reactive protein</measure>
    <time_frame>24* hours (*+/- 6 hours) after surgery.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>plasma C-reactive protein</measure>
    <time_frame>Preoperatively, 6 hours postoperatively, as well as postoperative day 3 and 5</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>postoperative inflammatory responses (IL-6, TNT)</measure>
    <time_frame>Preoperatively, 6 hours postoperatively, as well as postoperative day 1,3 and 5</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in plasma Syndecain-1sE-Selectin (CD62E)</measure>
    <time_frame>Preoperatively, 6 hours postoperatively, as well as postoperative day 1,3 and 5</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in plasma soluble thrombomodulin (sTM)(CD141)</measure>
    <time_frame>Preoperatively, 6 hours postoperatively, as well as postoperative day 1,3 and 5</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in plasma sE-Selectin (CD62E)</measure>
    <time_frame>Preoperatively, 6 hours postoperatively, as well as postoperative day 1,3 and 5</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in vascular endothelial growth factor (VEGF)</measure>
    <time_frame>Preoperatively, 6 hours postoperatively, as well as postoperative day 1,3 and 5</time_frame>
    <description>0 to 1 point: Not high risk; 2 to 3 points: High risk</description>
  </other_outcome>
  <other_outcome>
    <measure>quick Sequential Organ Failure Assessment score, qSOFA</measure>
    <time_frame>Assessed once preoperatively and 4 times daily during the first 5 postoperative days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Preload dependency via stroke volume(SV) guided resuscitation</measure>
    <time_frame>Preoperatively, 6 hours postoperatively, as well as postoperative day 1,3 and 5</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Fluid distribution, full body water via bioelectrical impedance vector analysis</measure>
    <time_frame>Preoperatively, 6 hours postoperatively, as well as postoperative day 1,3 and 5</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Peak flow measurements</measure>
    <time_frame>Once a day on postoperative day 1,3 and 5</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Postoperative need for antiemetic and analgesic beyond standard course</measure>
    <time_frame>Once a day during the the first 5 postoperative days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Mobilization, The Cumulated Ambulation Score (CAS)</measure>
    <time_frame>Once a day on postoperative day 1,3 and 5</time_frame>
    <description>The CAS describes the patient's independence with regard to three activities (getting in and out of bed, sit-to-stand-to-sit from a chair, and walking). Each activity is assessed on a three-point ordinal scale from 0-2 (0 = Not able to, despite human assistance and verbal cueing, 1 = Able to, with human assistance and/or verbal cueing from one or more persons, 2 = Able to safely, without human assistance or verbal cueing, use of a walking aid allowed) resulting in a total daily CAS score ranging from zero to six</description>
  </other_outcome>
  <other_outcome>
    <measure>Postoperative delirium via Confusion Assessment method scale</measure>
    <time_frame>Once a day during the the first 5 postoperative days</time_frame>
    <description>1.a: Acute onset&#xD;
1b: Fluctuating course, 2: inattention 3: disorganized thinking 4: altered level of conciosness At least one criterion must be met for a positive result</description>
  </other_outcome>
  <other_outcome>
    <measure>Postoperative resting pain measured according to Numeric Rating Scale (NRS)</measure>
    <time_frame>6 hours after surgery as well as once a day one postoperative day 1,3 and 5</time_frame>
    <description>0-10 where 0 is no pain and 10 is the worst pain imaginable</description>
  </other_outcome>
  <other_outcome>
    <measure>Postoperative pain during mobilization, measured according to Numeric Rating Scale (NRS)</measure>
    <time_frame>6 hours after surgery as well as once one postoperative day 1,3 and 5</time_frame>
    <description>0-10 where 0 is no pain and 10 is the worst pain imaginable</description>
  </other_outcome>
  <other_outcome>
    <measure>30-day postoperative mortality</measure>
    <time_frame>30 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>90-day postoperative mortality</measure>
    <time_frame>90 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>30-day postoperative complications</measure>
    <time_frame>30 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Length of ICU stay</measure>
    <time_frame>30 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Overall hospital stay</measure>
    <time_frame>30 days</time_frame>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Intestinal Obstruction and Ileus</condition>
  <condition>Perforated Viscus</condition>
  <condition>Sepsis</condition>
  <condition>Pathophysiology</condition>
  <condition>Inflammatory Response</condition>
  <arm_group>
    <arm_group_label>Intestinal obstruction, Dexamethasone 1 mg/kg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dexamethasone 1 mg/kg administered preoperatively as an i.v. infusion over 10-15 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intestinal obstruction, PLACEBO</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Physiologic saline, administered preoperatively as an i.v. infusion over 10-15 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Perforated viscus, Dexamethasone 1 mg/kg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dexamethasone 1 mg/kg administered preoperatively as an i.v. infusion over 10-15 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Perforated viscus, PLACEBO</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Physiologic saline, administered preoperatively as an i.v. infusion over 10-15 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone 1 mg/kg</intervention_name>
    <description>Dexamethasone 1 mg/kg administered as a single preoperative i.v. infusion over 10-15 min prior to general anaesthesia</description>
    <arm_group_label>Intestinal obstruction, Dexamethasone 1 mg/kg</arm_group_label>
    <arm_group_label>Perforated viscus, Dexamethasone 1 mg/kg</arm_group_label>
    <other_name>Dexa-ratiopharm</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Physiologic saline</intervention_name>
    <description>100 mL Physiologic saline administered as a single preoperative i.v., infusion over 10-15 min prior to general anaesthesia</description>
    <arm_group_label>Intestinal obstruction, PLACEBO</arm_group_label>
    <arm_group_label>Perforated viscus, PLACEBO</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Adults (18 years or over) undergoing emergency laparotomy (laparotomy or laparoscopy)&#xD;
             for following abdominal pathology:&#xD;
&#xD;
               1. Primary perforated viscus (perforated ulcer, small intestine or colon)&#xD;
&#xD;
               2. Primary intestinal obstruction ( small intestine or colon)&#xD;
&#xD;
          2. Provided verbal and written informed consent&#xD;
&#xD;
          3. Must speak and understand the Danish language&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Appendectomies, cholecystectomies, negative diagnostic laparoscopies/laparotomies,&#xD;
             herniotomies without bowel resections, sub-acute internal hernias after gastric bypass&#xD;
             surgery, sub-acute surgery for inflammatory bowel diseases.&#xD;
&#xD;
          2. Emergency re-operations after elective surgery owing to paralytic/obstructive ileus,&#xD;
             perforated viscus, anastomotic leakage&#xD;
&#xD;
          3. Reoperation owing to fascial separation with no other abdominal pathology identified&#xD;
             and sub-acute colorectal cancer-surgery will be excluded from the cohort. Sub-acute&#xD;
             surgery is defined as surgery planned within 48 hours.&#xD;
&#xD;
          4. Intestinal Ischemia&#xD;
&#xD;
          5. intraabdominal bleeding&#xD;
&#xD;
          6. Traumas, gynecological, urogenital and other vascular pathology, pregnant&#xD;
             participants.&#xD;
&#xD;
          7. Dementia and/or cognitive dysfunction (diagnosed).&#xD;
&#xD;
          8. Participants not oriented in time, place and person&#xD;
&#xD;
          9. Insuline treatment for diabetes mellitus type I and II&#xD;
&#xD;
         10. Current treatment with systemic glucocorticoids or immune suppressive treatment (&#xD;
             apart from inhalation steroids)&#xD;
&#xD;
         11. Allergies to trial medicine&#xD;
&#xD;
             -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicolai Bang Foss, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Dept. of Anaesthesiology and Intensive Care</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mirjana Cihoric, MD</last_name>
    <phone>22475828</phone>
    <email>mirjana.cihoric.03@regionh.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nicolai Bang Foss, Professor</last_name>
    <email>nicolai.bang.foss@regionh.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mirjana Cihoric</name>
      <address>
        <city>Hvidovre</city>
        <zip>2650</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mirjana Cihoric</last_name>
      <phone>22475828</phone>
      <email>mirjana.cihoric.03@regionh.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 3, 2021</study_first_submitted>
  <study_first_submitted_qc>March 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 10, 2021</study_first_posted>
  <last_update_submitted>March 8, 2021</last_update_submitted>
  <last_update_submitted_qc>March 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Copenhagen University Hospital, Hvidovre</investigator_affiliation>
    <investigator_full_name>Mirjana Cihoric</investigator_full_name>
    <investigator_title>MD, Research fellow</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intestinal Obstruction</mesh_term>
    <mesh_term>Emergencies</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

